We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Finger-Prick Tests Show Antibody Response to SARS-CoV-2 Reduces Over Time

By HospiMedica International staff writers
Posted on 28 Oct 2020
Print article
Illustration
Illustration
Tests conducted on more than 365,000 people in the UK have shown that the antibody response to the SARS-CoV-2 virus that causes COVID-19 wanes over time.

Scientists from the Imperial College London (London, UK) conducted an analysis of finger-prick tests to detect coronavirus antibodies in the blood. When present these indicate that a person has been previously infected with the virus. The testing kits, called Lateral Flow Tests, detect antibodies above a particular concentration in the blood, and do not measure the amount of antibodies in a particular person. The tests are sent out to randomly-selected adult volunteers across the UK to carry out at home.

The latest report includes findings from three rounds of testing carried out over a three-month period. There were 17,576 positive results across all three rounds, around 30% of whom did not report any COVID-19 symptoms. After accounting for the accuracy of the test, confirmed by laboratory evaluation, and the country’s population characteristics, the study found that antibody prevalence declined from 6.0% to 4.8% and then 4.4% over the three months. This was found across all ages but the smallest drop was found in the youngest age group, aged 18-24, falling from 7.9% to 6.7% (14.9%), while the largest was found in the oldest group, aged 75 and above, declining from 3.3% to 2.0% (39%).

All parts of the UK showed a fall in prevalence, except the West Midlands which increased in round two and then declined in round three. London maintained the highest prevalence of antibodies across the different rounds, with 9% testing positive in round three, compared with the South West which consistently had the smallest proportion. The decline was largest in people who did not report a history of COVID-19, dropping by almost two-thirds (64.0%) between rounds one and three, compared to a decrease of 22.3% in people who had an infection confirmed by lab testing. Health and care workers, ethnic minority groups, and those living in deprived areas and large households also had the greatest burden of past infection. These findings suggest that there may be a decline in the level of immunity in the population in the months following the first wave of the epidemic.

“Our study shows that over time there is a reduction in the proportion of people testing positive for antibodies. It remains unclear what level of immunity antibodies provide, or for how long this immunity lasts,” said Professor Paul Elliott study author, Imperial College London.

“This very large study has shown that the proportion of people with detectable antibodies is falling over time. But we don’t yet know whether this will leave these people at risk of reinfection with the virus that causes COVID-19,” added Prof Helen Ward study author, Imperial College London.

Related Links:
Imperial College London

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Examination Table
Powerline Backrest Top

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.